{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:59:42Z","timestamp":1794448782140,"version":"4.9.1"},"reference-count":40,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2025,11,13]]},"abstract":"<jats:p>Tendencias en las pr\u00e1cticas de control de la enteritis necr\u00f3tica y la coccidiosis en las explotaciones av\u00edcolas de Canad\u00e1, 2018-2023. La enteritis necr\u00f3tica (EN) y la coccidiosis contin\u00faan siendo diagnosticadas en la avicultura de Canad\u00e1. Desde 2013, el Programa Integrado Canadiense de Vigilancia de la Resistencia a los Antimicrobianos (CIPARS) recopila datos sobre el uso de antimicrobianos y la resistencia a los mismos en explotaciones de pollos de engorde y pavos, y desde 2021 tambi\u00e9n incluye a las explotaciones de ponedoras. Este estudio describe las estrategias de control de enfermedades ent\u00e9ricas utilizadas en la producci\u00f3n av\u00edcola entre 2018 y 2023, bas\u00e1ndose en los datos de las granjas reportados a CIPARS. En pollos de engorde, el 85% (51.7 mg\/kg de biomasa) del total de antimicrobianos de importancia m\u00e9dica se utiliz\u00f3 para el control de la enteritis necr\u00f3tica, frente al 51% (28.1 mg\/kg de biomasa) en pavos y el 74% (16 mg\/kg de biomasa) en aves de postura. Desde 2019, la utilizaci\u00f3n de clases de antimicrobianos para el control de la enteritis necr\u00f3tica ha disminuido tras la eliminaci\u00f3n voluntaria del uso preventivo de macr\u00f3lidos, penicilinas y estreptograminas. La bacitracina se mantuvo como el antimicrobiano m\u00e1s utilizado para el control de la enteritis necr\u00f3tica en todas las especies. Para el control de la coccidiosis, los ion\u00f3foros se utilizaron con mayor frecuencia que los coccidiost\u00e1ticos qu\u00edmicos, en una proporci\u00f3n de 2.5:1 en pollos de engorde (ion\u00f3foros: 2892.9 kg; coccidiost\u00e1ticos qu\u00edmicos: 1126.6 kg) y de 2.4:1 en pavos (ion\u00f3foros: 1840.2 kg; coccidiost\u00e1ticos qu\u00edmicos: 749.9 kg). Las explotaciones de aves de postura utilizaron exclusivamente monensina (39.3 kg) y amprolio (31.6 kg). Durante el periodo de vigilancia, la diversidad de coccidiost\u00e1ticos utilizados en pollos de engorde y pavos se mantuvo estable. Los programas de control alterno\/dual (58%) se utilizaron com\u00fanmente en pollos de engorde, mientras que los programas continuos\/directos (51%) predominaron en pavos. Cabe destacar que est\u00e1n surgiendo o se est\u00e1n implementando estrategias alternativas de control de enfermedades, como la vacunaci\u00f3n. La vacuna contra Clostridium perfringens se utiliz\u00f3 en el 1% de los pollos de engorde, y las vacunas contra la coccidiosis se administraron en el 13% de las parvadas de pollos de engorde, el 16% de las parvadas de pavos y el 29% de las parvadas de ponedoras. Estas alternativas no antimicrobianas pueden reducir la dependencia del uso de antimicrobianos. A pesar de los cambios en las pr\u00e1cticas del uso de antimicrobianos, la mortalidad y el diagn\u00f3stico de enfermedades ent\u00e9ricas se mantuvieron estables. Los hallazgos resaltan la importancia de preservar la eficacia de los antimicrobianos, incluidos los coccidiost\u00e1ticos, para la salud intestinal. La vigilancia continua es crucial para monitorear las tendencias en las estrategias de control de enfermedades y evaluar su impacto en la salud y la producci\u00f3n av\u00edcola.<\/jats:p>","DOI":"10.1637\/aviandiseases-d-25-00058","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:20:36Z","timestamp":1767093636000},"page":"384-394","source":"Crossref","is-referenced-by-count":2,"title":["Trends in Necrotic Enteritis and Coccidiosis Control Practices in Canadian Poultry Flocks, 2018\u20132023"],"prefix":"10.1637","volume":"69","author":[{"given":"Agnes","family":"Agunos","sequence":"first","affiliation":[{"name":"Center for Foodborne, Environmental, and Zoonotic Infectious Diseases (CFEZID), Public Health Agency of Canada (PHAC), 370 Speedvale Avenue West, Guelph, Ontario, N1H 7M7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Gow","sequence":"additional","affiliation":[{"name":"Centre for Foodborne, Environmental, and Zoonotic Infectious Diseases (CFEZID), Public Health Agency of Canada (PHAC), 52 Campus Drive, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Reid-Smith","sequence":"additional","affiliation":[{"name":"Center for Foodborne, Environmental, and Zoonotic Infectious Diseases (CFEZID), Public Health Agency of Canada (PHAC), 370 Speedvale Avenue West, Guelph, Ontario, N1H 7M7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1212","reference":[{"key":"5","doi-asserted-by":"crossref","unstructured":"RB. Williams,  \"Avian Pathol.\"  34, \"Intercurrent coccidiosis and necrotic enteritis of chickens: rational, integrated disease management by maintenance of gut integrity.\" 159 (2005)","DOI":"10.1080\/03079450500112195"},{"key":"1","unstructured":"\"Canadian Integrated Program for Antimicrobial Resistance Surveillance 2019: Broiler chicken report.\"  (2022)"},{"key":"7","unstructured":"\"Categorization of antimicrobial drugs based on importance in human medicine.\"  (2009)"},{"key":"8","unstructured":"\"List A: list of certain antimicrobial active pharmaceutical ingredients [accessed 2025 Jun 13].\"  (2024)"},{"key":"9","unstructured":"\"Regulation (EC) No 1831\/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition, No. 1831\/2003.\"  (2013)"},{"key":"11","unstructured":"\"Chicken Farmers of Canada' AMU strategy, a prescription for change.\"  (2018)"},{"key":"12","unstructured":"\"Turkey Farmers of Canada's guidelines for antimicrobial use in the turkey industry.\"  (2019)"},{"key":"13","unstructured":"\"Food and Drugs Act. Regulations amending the food and drug regulations (veterinary drugs\u2014antimicrobial resistance).\"  151, (2017)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"A Agunos, A Deckert, D Leger, et al.  \"Avian Dis.\"  63, \"Antimicrobials used for the therapy of necrotic enteritis and coccidiosis in broiler chickens and turkeys in Canada, farm surveillance results (2013\u20132017).\" 433 (2019)","DOI":"10.1637\/11971-091718-Reg.1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"S Noack, HD Chapman, PM Selzer,  \"Parasitol Res.\"  118, \"Anticoccidial drugs of the livestock industry.\" 2009 (2019)","DOI":"10.1007\/s00436-019-06343-5"},{"key":"16","unstructured":"\"Compendium of medicating ingredient brochure.\"  (2024)"},{"key":"17","unstructured":"\"Compendium of veterinary products.\"  (2025)"},{"key":"18","doi-asserted-by":"publisher","unstructured":"GF Mathis, B Lumpkins, HM Cervantes, et al.  \"Poult Sci.\"  104, \"Coccidiosis in poultry: disease mechanisms, control strategies, and future directions.\" 104663 (2025)","DOI":"10.1016\/j.psj.2024.104663"},{"key":"19","doi-asserted-by":"publisher","unstructured":"HW Peek  and WJM Landman  \"Vet Q.\"  31, \"Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies.\" 143 (2011)","DOI":"10.1080\/01652176.2011.605247"},{"key":"20","doi-asserted-by":"publisher","unstructured":"I Bueno, I Ricke, H Hwang, et al.  \"Avian Dis.\"  67, \"Efficacy of antibiotic and non-antibiotic interventions in preventing and treating necrotic enteritis in broiler chickens: a systematic review.\" 20 (2023)","DOI":"10.1637\/aviandiseases-D-22-00069"},{"key":"21","doi-asserted-by":"publisher","unstructured":"RJ. Moore,  \"Anim Nutr.\"  16, \"Necrotic enteritis and antibiotic-free production of broiler chickens: challenges in testing and using alternative products.\" 288 (2023)","DOI":"10.1016\/j.aninu.2023.08.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"N Mishra  and JA Smyth  \"Vaccine.\"  35, \"Oral vaccination of broiler chickens against necrotic enteritis using a non-virulent NetB positive strain of Clostridium perfringens type A.\" 6858 (14)","DOI":"10.1016\/j.vaccine.2017.10.030"},{"key":"24","doi-asserted-by":"crossref","unstructured":"SP Fernandes da Costa, D Mot, M Bokori-Brown, et al.  \"Vaccine.\"  31, \"Protection against avian necrotic enteritis after immunisation with NetB genetic or formaldehyde toxoids.\" 4003 (2013)","DOI":"10.1016\/j.vaccine.2013.05.063"},{"key":"25","doi-asserted-by":"crossref","unstructured":"RR Kulkarni, VR Parreira, S Sharif, et al.  \"Clin Vaccine Immunol.\"  14, \"Immunization of broiler chickens against Clostridium perfringens\u2013induced necrotic enteritis.\" 1070 (2017)","DOI":"10.1128\/CVI.00162-07"},{"key":"27","unstructured":"\"Vaccination against necrotic enteritis with the Clostridium perfringens type A vaccine in Canada.\"  (2025)"},{"key":"28","doi-asserted-by":"crossref","unstructured":"RS. Singer,  \"Front Vet Sci.\"  10, \"Estimates of on-farm antimicrobial usage in egg production in the United States, 2016\u20132021.\" 1135377 (2023)","DOI":"10.3389\/fvets.2023.1135377"},{"key":"29","doi-asserted-by":"crossref","unstructured":"H Medrano, L Lee, V Young, et al.  \"Int J Food Microbiol.\"  412, \"Surveillance of antimicrobial resistance in Escherichia coli, Salmonella, and Campylobacter recovered from laying hens, their environment and products in Canada indicated a stable level of resistance to critically important antimicrobials, in varying time periods between 2007 and 2021.\" 110541 (2024)","DOI":"10.1016\/j.ijfoodmicro.2023.110541"},{"key":"30","unstructured":"\"veterinary antimicrobial sales reporting (VASR).\"  (2025)"},{"key":"31","doi-asserted-by":"crossref","unstructured":"RC Robbins, RS Singer, GK Innes, et al.  \"J Am Vet Med Assoc.\"  262, \"Animal drug shortages limit veterinary therapeutic options and introduce artifacts in antimicrobial sales reporting.\" 576 (2024)","DOI":"10.2460\/javma.23.10.0603"},{"key":"34","doi-asserted-by":"crossref","unstructured":"S Simjee, G Gould, L Maduro, et al.  \"J Antimicrob Chemother.\"  78, \"No change in avilamycin (Surmax(R) Premix) minimum inhibitory concentration for Clostridium perfringens isolates recovered from poultry up to 7 years post-approval in Canada.\" 1278 (2023)","DOI":"10.1093\/jac\/dkad089"},{"key":"35","doi-asserted-by":"crossref","unstructured":"A Gholamiandehkordi, V Eeckhaut, A Lanckriet, et al.  \"Vet Res Commun.\"  33, \"Antimicrobial resistance in Clostridium perfringens isolates from broilers in Belgium.\" 1031 (2009)","DOI":"10.1007\/s11259-009-9306-4"},{"key":"36","doi-asserted-by":"crossref","unstructured":"RS Singer  and TJ Johnson  \"J Food Prot.\"  87, \"Assessing the risk of antimicrobial resistant enterococcal infections in humans due to bacitracin usage in poultry.\" 100267 (2024)","DOI":"10.1016\/j.jfp.2024.100267"},{"key":"37","unstructured":"\"Methods of production claims, \u201craised without antibiotics.\"  (2025)"},{"key":"38","doi-asserted-by":"crossref","unstructured":"LR McDougald, AL Fuller, GF Mathis, et al.  \"Avian Dis.\"  34, \"Efficacy of maduramicin ammonium against coccidiosis in turkeys under laboratory and floor-pen conditions.\" 634 (1990)","DOI":"10.2307\/1591256"},{"key":"39","doi-asserted-by":"crossref","unstructured":"LR McDougald, GT Wang, S Kantor, et al.  \"Avian Dis.\"  31, \"Efficacy of maduramicin against ionophore-tolerant field isolates of coccidia in broilers.\" 302 (1987)","DOI":"10.2307\/1590876"},{"key":"40","unstructured":"\"2015\/16 annual report.\"  (2019)"},{"key":"32","doi-asserted-by":"crossref","unstructured":"G Chalmers, SW Martin, DB Hunter, et al.  \"Vet Microbiol.\"  127, \"Genetic diversity of Clostridium perfringens isolated from healthy broiler chickens at a commercial farm.\" 116 (2008)","DOI":"10.1016\/j.vetmic.2007.08.008"},{"key":"33","doi-asserted-by":"crossref","unstructured":"S Mwangi, J Timmons, S Fitz-coy, et al.  \"Poult Sci.\"  98, \"Characterization of Clostridium perfringens recovered from broiler chicken affected by necrotic enteritis.\" 128 (2019)","DOI":"10.3382\/ps\/pey332"},{"key":"4","unstructured":"B Wade  and A Keyburn  \"World Poultry.\"  31, \"The true cost of necrotic enteritis.\" 16 (2015)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"LR McDougald, HM Cervantes, MC Jenkins, et al.  \"Diseases of poultry.\"  \"Protozoal infections.\" 1192 (2020)","DOI":"10.1002\/9781119371199.ch28"},{"key":"10","doi-asserted-by":"crossref","unstructured":"M Casewell, C Friis, E Marco, et al.  \"J Antimicrob Chemother.\"  52, \"The European ban on growth-promoting antibiotics and emerging consequences for human and animal health.\" 159 (2003)","DOI":"10.1093\/jac\/dkg313"},{"key":"6","unstructured":"A Agunos, C Carson, D Leger,  \"Can Vet J.\"  54, \"Antimicrobial therapy of selected diseases in turkeys, laying hens, and minor poultry species in Canada.\" 1041 (2013)"},{"key":"2","doi-asserted-by":"publisher","unstructured":"M Boulianne, FA Uzal, K Opengart,  \"Diseases of poultry.\"  \"Clostridial diseases.\" 966 (2020)","DOI":"10.1002\/9781119371199.ch22"},{"key":"22","doi-asserted-by":"publisher","unstructured":"M Alizadeh, B Shojadoost, N Boodhoo, et al.  \"Anim Health Res Rev.\"  22, \"Necrotic enteritis in chickens: a review of pathogenesis, immune responses and prevention, focusing on probiotics and vaccination.\" 147 (2021)","DOI":"10.1017\/S146625232100013X"},{"key":"26","doi-asserted-by":"crossref","unstructured":"RR Kulkarni, VR Parreira, S Sharif, et al.  \"Vaccine.\"  26, \"Oral immunization of broiler chickens against necrotic enteritis with an attenuated Salmonella vaccine vector expressing Clostridium perfringens antigens.\" 4194 (2008)","DOI":"10.1016\/j.vaccine.2008.05.079"}],"container-title":["Avian Diseases"],"original-title":[],"link":[{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-69\/issue-4\/aviandiseases-D-25-00058\/Trends-in-Necrotic-Enteritis-and-Coccidiosis-Control-Practices-in-Canadian\/10.1637\/aviandiseases-D-25-00058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:49:37Z","timestamp":1791236977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-69\/issue-4\/aviandiseases-D-25-00058\/Trends-in-Necrotic-Enteritis-and-Coccidiosis-Control-Practices-in-Canadian\/10.1637\/aviandiseases-D-25-00058.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-25-00058","relation":{},"ISSN":["0005-2086","1938-4351"],"issn-type":[{"value":"0005-2086","type":"print"},{"value":"1938-4351","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}